Rhinophyma treated by argon laser
- 1 January 1983
- journal article
- research article
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 2 (3) , 211-215
- https://doi.org/10.1002/lsm.1900020304
Abstract
Results are reported of rhinophyma treated by argon laser. The therapy is assumed to be based on two features: first, selective coagulation of the blood capillaries which cause redness of the nose and which feed the hypertrophic regions; second, direct coagulation shrinkage of the hypertrophic connective tissue. The therapy is simple, causes no noticeable discomfort, requires no (local) anaesthesia or admission, and can be performed more than once. Thirteen patients were treated, eleven men and two women. Systemic treatment could be stopped in all but one case (seven patients). Two out of ten patients still use resorcinol but at a reduced freqency. The general result is a smooth and more natural appearance of the nose without redness. Pustulosis has become an exception.Keywords
This publication has 7 references indexed in Scilit:
- A model approach to laser coagulation of dermal vascular lesionsArchives of Dermatological Research, 1981
- The Argon Laser for Cutaneous LesionsJAMA, 1981
- Removal of Rhinophyma With the Carbon Dioxide Laser: A Preliminary ReportJAMA Otolaryngology–Head & Neck Surgery, 1980
- The carbon dioxide laser in the treatment of superficial telangiectasesBritish Journal of Plastic Surgery, 1975